(firstQuint)Safety and Efficacy of Generic Diclofenac Epolamine Acute Pain Due to Minor Ankle Sprain.

 To evaluate the therapeutic equivalence and safety of generic diclofenac epolamine 1.

3% patch (Watson Laboratories, Inc.

) and Flector(R) (diclofenac epolamine 1.

3% patch) (Pfizer) in the treatment of acute pain due to minor ankle sprain.

 To demonstrate the superiority of the efficacy of the test and reference products over that of the vehicle control in the treatment of acute pain due to minor ankle sprain.

 To access application site reactions and patch adhesion between treatment groups.

.

 Safety and Efficacy of Generic Diclofenac Epolamine Acute Pain Due to Minor Ankle Sprain@highlight

To demonstrate the therapeutic efficacy of a generic diclofenac epolamine patch against Flector patch in the treatment of pain in subjects with minor ankle sprain